Lin Wang

机构：Chinese Academy of Medical Sciences & Peking Union Medical College, Baotou Central Hospital, Shanxi Academy of Medical Sciences, Baotou Medical College · ORCID：0000-0002-0503-7860

发表论文 6 篇 · 总被引 64 次 · h-index 5

代表论文

• Chinese expert consensus on the diagnosis and treatment of malignant pleural mesothelioma (2023 · Thoracic Cancer · 被引 20)
• Prognostic and predictive impact of neutrophil‐to‐lymphocyte ratio and HLA‐I genotyping in advanced esophageal squamous cell carcinoma patients receiving immune checkpoint inhibitor monotherapy (2022 · Thoracic Cancer · 被引 17)
• A systematic review on the epidemiology and treatment options of multiple Myeloma in Asia (2024 · Heliyon · 被引 9)
• First-line serplulimab plus chemotherapy with or without HLX04 versus chemotherapy in locally advanced or metastatic non-squamous non-small-cell lung cancer (ASTRUM-002): a randomised, double-blind, multicentre phase 3 trial (2025 · The Lancet Respiratory Medicine · 被引 7)
• Expert consensus on the diagnosis and treatment of non-small cell lung cancer with MET alteration (2025 · Cancer Biology and Medicine · 被引 7)
• Perioperative treatment and biomarker analysis of LP002 , an anti‐PD‐L1 antibody, plus chemotherapy in resectable gastric and gastroesophageal junction cancer (2022 · Cancer Medicine · 被引 4)